Table 3.
Logistic regression: predictors of symptomatic intracranial hemorrhage.
| OR (IC 95%) | p-value | |
|---|---|---|
| Prior mRS | 1.43 (1.03–1.99) | 0.03 |
| Baseline NIHSS | 1 (0.96–1.05) | 0.72 |
| ASPECTS | 0.71 (0.61–0.84) | <0.001 |
| Treatment with VKA | 1.89 (1.01–3.51) | 0.04 |
| Treatment with DOACs | 0.32 (0.04–2.42) | 0.27 |
| Vessel occlusion MCA-M1 | 0.91 (0.71–1.16) | 0.46 |
| Age | 1.01 (0.99–1.04) | 0.2 |
| Arterial Hypertension | 0.89 (0.51–1.55) | 0.68 |
| Hypercholesterolemia | 0.82 (0.49–1.37) | 0.46 |
| Atrial fibrillation | 0.79 (0.54–1.17) | 0.25 |
mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; ASPECTS, Alberta Stroke Program Early CT Score; MCA, middle cerebral artery; VKA, vitamin K antagonist.